New Tool Gauges Post–CAR T Relapse Risk in Multiple Myeloma

  • 📰 Medscape
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 55%

United States Headlines News

United States Latest News,United States Headlines

A simple prediction model developed with US and European cohorts effectively predicted relapse risk in multiple myeloma patients post anti-BCMA CAR-T therapy.

Receive email when new articles are published onA simple prediction model developed with US and European cohorts shows accuracy in identifying patients with relapsed/refractory multiple myeloma who are or are not at high risk for relapsing after treatment with anti–B-cell maturation antigen chimeric antigen receptor T therapy.

Of the patients, 171 were infused with ide-cel, 38 with cilta-cel, and 60 with an academic CAR-T therapy. The patients had a median age of 63, and extramedullary disease was more common in the US cohort vs European in the European cohort vs US negativity rate at any time was 29% and 37%, respectively, and rates of complete response at day 30 were 29% and 26%, respectively.

"Clinically, my hope that this will help us tailor post–CAR-T interventions according to each patient's risk profile," he said. "Exhausted T-cells at collection mean exhausted CAR T-cells at infusion, and so the negative prognostic significance of elevated ferritin — which we don't always check before CAR-T — makes sense."

"Caveats include that factors beyond the baseline features can further influence outcomes," Dr Banerjee noted.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Save automatically online with our NEW Shop TODAY Savings toolShop TODAY savings finds the best discounts from over 40,000 online stores so you never have to search for deals. Download the shopping extension for exclusive promo codes.
Source: TODAYshow - 🏆 389. / 55 Read more »

Dyson Airstrait review: We were one of the first to try Dyson's new hair toolCheck our beauty team's Dyson Airstrait review. We were one of the first to try Dyson's new wet-to-dry hair straightener. Here's our expert verdict.
Source: RedMagDaily - 🏆 312. / 61 Read more »

Google’s new tool makes customer service calls so much simplerGoogle just released a new Search Labs experiment that calls a customer service number and then waits on hold for you.
Source: BGR - 🏆 234. / 63 Read more »

New AI Tool Can Generate Images in Under Two Seconds Without Expensive HardwareSouth Korean scientists have developed a new AI tool called 'KOALA' that can generate images quickly without requiring expensive hardware. The tool uses knowledge distillation to compress the size of the image generation model, making it more efficient.
Source: LiveScience - 🏆 538. / 51 Read more »

Pill Identification ToolUse WebMD’s Pill Identifier to find and identify any over-the-counter or prescription drug, pill, or medication by color, shape, or imprint and easily compare pictures of multiple drugs.
Source: WebMD - 🏆 709. / 51 Read more »

Generic Spondyloarthritis Screening Tool Needed Across Comorbid Diseases to Speed Referral, DiagnosisA comparison of screening tools for SpA in conditions that commonly co-occur with the disease revealed few screening tool options for patients with uveitis or IBD, compared with psoriasis.
Source: Medscape - 🏆 386. / 55 Read more »